Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2440352
Max Phase: Preclinical
Molecular Formula: C33H51N9O6S
Molecular Weight: 701.89
Molecule Type: Small molecule
Associated Items:
ID: ALA2440352
Max Phase: Preclinical
Molecular Formula: C33H51N9O6S
Molecular Weight: 701.89
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccc(/C=C2\SC(=O)N(CCCC)C2=O)cc1)C(N)=O
Standard InChI: InChI=1S/C33H51N9O6S/c1-3-5-10-23(27(35)43)39-29(45)24(11-7-8-17-34)41-30(46)25(12-9-18-38-32(36)37)40-28(44)22-15-13-21(14-16-22)20-26-31(47)42(19-6-4-2)33(48)49-26/h13-16,20,23-25H,3-12,17-19,34H2,1-2H3,(H2,35,43)(H,39,45)(H,40,44)(H,41,46)(H4,36,37,38)/b26-20-/t23-,24-,25-/m0/s1
Standard InChI Key: RKSZQXKROMDUKA-OPIGBIQLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 701.89 | Molecular Weight (Monoisotopic): 701.3683 | AlogP: 1.66 | #Rotatable Bonds: 22 |
Polar Surface Area: 255.69 | Molecular Species: BASE | HBA: 9 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.21 | CX Basic pKa: 11.73 | CX LogP: 0.66 | CX LogD: -4.01 |
Aromatic Rings: 1 | Heavy Atoms: 49 | QED Weighted: 0.04 | Np Likeness Score: -0.53 |
1. Nitsche C, Schreier VN, Behnam MA, Kumar A, Bartenschlager R, Klein CD.. (2013) Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture., 56 (21): [PMID:24083834] [10.1021/jm400828u] |
Source(1):